glp-1 adoption Receptor Agonist Market Size & Analysis, 2026-2033 GLP-1 Drugs Impact the Food

That matters, because many GLP-1 benefits appear to fade when treatment stops

The results demonstrated that the 25mg daily pill delivered clinically meaningful weight loss: Average weight loss of 13.6-16.6% compared to 2.2-2.7% with placebo 76% of participants achieved at least 5% weight loss versus 31% on placebo Over 30% achieved 20% or greater weight loss Significant improvements in blood pressure, cholesterol, and inflammatory markers These results are comparable to what weve seen with injectable Wegovy, which typically produces 12-15% weight loss

Because compounded versions are not FDA-approved, they are typically not covered by insurance

Prioritize protein and fiber